The ESP prosthetic disc is the result of 10 years of collaborative research work at the HôpitalPitié Salpêtrière in Paris, the French Atomic Energy Commission (CEA) and the UniversitéParis VI, and was driven by the Oséo Innovation contest in France.
The LP-ESP® disc prosthesis is intended to replace a damaged or diseased disc between two vertebrae of the lumbar spine.
The LP-ESP® disc prosthesis is designed to reproduce the natural behavior and physiological functions of a healthy disc.
Thanks to its viscoelastic PCU core, the LP-ESP® enable mimic natural motion in all six degrees of freedom (flexion-extension, lateral bending, translation, axial rotation and shock absorption or load bear.
This flexible cushion, attached to the two metal endplates, provides the disc with its shock-absorbing function and limits the release of particles into the body and the calcification of deformable parts.
Indications
The LP-ESP® lumbar disc prosthesis is designed for the treatment of degenerative disc disease (DDD) in the lumbar column.
Disc condition is evaluated based on the convergence of data from clinical examinations and imaging. The LP-ESP® lumbar disc prosthesis is a medical device for primary treatment.
Features
Between the 2 titanium end-plates the elastomeric parts are injected for controled resistance to compression, flexion and rotation.
These elastomeric parts are concentric and their fixation prohibits micro motion.
- Minimally invasive anterior approach which allows reduced hospital stay and improves rehabilitation
- ESP should give a significant reduction in pain severity, re-establish lumbar curvature and natural disc functions
- ESP allows quick return to normal daily activities
- Over 10 years of research and development
- Marketedsince 2024
- 6° of freedom
- Primary stability thanks to spikes allowing the prosthesis to be implanted anteriorly as well as antero-lateraly and to face difficult soft tissue situations
- Adaptive center of rotation
- No surface bearing for an increased lifetime
- Improvedstability
- Shock absorbing
- Designed to fit and restore patient lordosis
Product Range
- 1 footprint (28x39mm)
- 2 heights (10 & 12mm)
- 3 lordosis (7°, 9°, 11°)
- A total of 6 references
About Spineway Group
About Spineway
Spineway is an independent French company, founded in Lyon in 2005, and dedicated to the design and development of advanced technologies for spine surgery. Backed by 100% French know-how, we have contributed to more than 125,000 surgeries over the past 20 years. With the acquisitions of Distimp in 2021 and Spine Innovations in 2022, we have broadened our offering by combining complementary product portfolios and territories, while offering solutions to treat new pathologies.
Our CE0459 certified medical devices reflect our commitment to quality and safety. Spineway also holds 14 patent families in France and abroad, testifying to our commitment to innovation.
Spineway positions itself as much more than just a manufacturer, establishing close partnerships with surgeons. We offer an international program of customized training courses in surgical techniques, to meet the exact requirements and expectations of practitioner. Our 40 enthusiastic employees work side by side with you, listening to your expectations, to co-construct solutions adapted to a constantly evolving practice.
As a company on a human scale, we value the development of our teams, enabling them to give the best of themselves. Together, we are committed to improving the quality of care and advancing medicine.
About Spine Innovations
Spine Innovations is the manufacturer of the ESP disc protheses. The ESP disc prothesis is the result of 10 years of collaborative research work at the HôpitalPitié Salpêtrière in Paris, the French Atomic Energy Commission (CEA) and the UniversitéParis VI, and was driven by the Oséo Innovation contest in France.
Unlike traditional articulated prostheses composed of moving metal parts, ESP prostheses use a viscoelastic core designed to replicate the biomechanical behavior of a healthy intervertebral disc.
This technology is specifically designed to:
- preserve mobility in the operated segment;
- replicate the six physiological degrees of freedom;
- provide shock absorption similar to that of a natural disc.
The LP-ESP (lumbar prosthesis) received its CE marking in 2007and the CP-ESP® (cervical prosthesis) in 2012.
In 2020, Spine Innovation, an independent company, was founded to focus on the development, production, and marketing of ESP prostheses. In July 2022, Spineway acquired 100% of Spine Innovations as part of its external growth strategy.
About Distimp
From its inception in 2018, Distimp has focused on offering innovative solutions while drawing on a strong network of surgeons, particularly in France and Europe.
Spineway finalized the acquisition of 100% of Distimpin June 2021.
This transaction served several strategic objectives:
- to expand the group’s product portfolio;
- to strengthen its presence in the French market;
- to benefit from the network of surgeons developed by Distimp;
- to enhance its offering with new technical solutions for spinal surgery.
